Overview

Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients

Status:
Terminated
Trial end date:
2002-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the safety of risperidone treatment in acute psychotic patients that require an admission into emergency department. The effectiveness of risperidone in controlling acute psychotic symptomatology and incidence, severity and risk of psychomotor agitation in acute psychotic patients was also studied.
Details
Lead Sponsor:
Janssen-Cilag, S.A.
Treatments:
Risperidone